LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping
J Neuropathol Exp Neurol
.
2024 Jan 19;83(2):136-138.
doi: 10.1093/jnen/nlad104.
Authors
Oumaima Aboubakr
1
2
3
,
Alice Métais
1
3
4
,
François Doz
3
5
6
,
Raphaël Saffroy
7
,
Julien Masliah-Planchon
8
,
Lauren Hasty
1
,
Kevin Beccaria
2
3
,
Olivier Ayrault
9
10
,
Christelle Dufour
11
,
Pascale Varlet
1
3
4
,
Arnault Tauziède-Espariat
1
3
4
Affiliations
1
Department of Neuropathology, GHU Paris-Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris, France.
2
Department of Pediatric Neurosurgery, Necker Hospital, APHP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
3
Université de Paris, Paris, France.
4
Institute of Psychiatry and Neurosciences de Paris (IPNP), UMR S1266, INSERM, IMA-BRAIN, Paris, France.
5
Institut Curie, Paris Sciences Lettres University, SIREDO, INSERM U830, Laboratory of translational research in pediatric oncology, Paris, France.
6
INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
7
Department of Biochemistry and Oncogenetics, Paul Brousse Hospital, Villejuif, France.
8
Institut Curie, Laboratory of Somatic Genetics, PMDT, Paris Sciences Lettres Research University Paris, France.
9
Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
10
Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.
11
Department of Children and Adolescents Oncology, Gustave Roussy, Paris Saclay University, Villejuif, France.
PMID:
38237134
DOI:
10.1093/jnen/nlad104
No abstract available
Publication types
Letter
MeSH terms
Biomarkers
Cerebellar Neoplasms* / diagnosis
Humans
Immunohistochemistry
Medulloblastoma* / diagnosis
beta Catenin
Substances
beta Catenin
Biomarkers